Literature DB >> 12544504

Risk factors and risk reduction of breast and ovarian cancer.

Cecile T M Brekelmans1.   

Abstract

PURPOSE OF REVIEW: Breast and ovarian cancer remain a significant burden for women living in the Western world. This paper reviews the risk factors and current strategies to prevent these diseases. RECENT
FINDINGS: Established factors associated with the risk of breast cancer include family history, reproductive factors and lactation, as well as age at menarche and menopause. Hormone replacement therapy increases the risk, whereas oral contraceptives probably confer no increased risk. Alcohol moderately increases the risk, whereas a diet rich in folate and carotenoids might be protective. The role of other dietary factors, smoking and physical exercise remain unclear. Important risk factors for ovarian cancer are reproductive factors and possibly the long-term use of hormone replacement therapy. The risk is decreased by oral contraceptives. In carriers of a BRCA1 or BRCA2 gene mutation, prophylactic surgery can significantly reduce the risk of breast as well as ovarian cancer. Tamoxifen may be considered as a chemopreventive agent in women with a high risk of breast cancer, including carriers of a BRCA2 mutation, but is probably not effective in BRCA1 carriers.
SUMMARY: During the period of this review, the importance of several known risk factors was confirmed, whereas the effects of other factors became more clear. Chemoprevention and prophylactic surgery have emerged as preventative options that can reduce the risk of breast and ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544504     DOI: 10.1097/00001703-200302000-00010

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  37 in total

Review 1.  Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

Authors:  Gwendal Lazennec
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

2.  The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.

Authors:  Shujing Shi; Lingyan Qin; Mengqiu Tian; Mao Xie; Xiaoxue Li; Chenglin Qi; Xiang Yi
Journal:  Tumour Biol       Date:  2014-03-06

3.  Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

Authors:  Yue Wang; Hong Liao; Holly C Zheng; Linmin Li; Lin Jia; Zhengbo Zhang; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

4.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

5.  Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.

Authors:  Yan Huang; Yuqi Zhou; Lingfang Xia; Jia Tang; Hao Wen; Meiqin Zhang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

6.  Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population.

Authors:  Adrianna Mostowska; Stefan Sajdak; Piotr Pawlik; Margarita Lianeri; Pawel P Jagodzinski
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-15

Review 7.  Ovarian cancer (advanced).

Authors:  Sean Kehoe; Jo Morrison
Journal:  BMJ Clin Evid       Date:  2009-01-16

8.  Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women.

Authors:  Alamtaj Samsami Dehaghani; Alireza Fotouhi Ghiam; Marjan Hosseini; Sareh Mansouri; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

9.  LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment.

Authors:  T Martijn Kuijper; Kirsten Ruigrok-Ritstier; Miriam Verhoef-Post; Djura Piersma; Martijn W P Bruysters; Els M J J Berns; Axel P N Themmen
Journal:  Mol Cell Endocrinol       Date:  2009-01-20       Impact factor: 4.102

10.  Effects of lifelong exercise training on mammary tumorigenesis induced by MNU in female Sprague-Dawley rats.

Authors:  Ana I Faustino-Rocha; Adelina Gama; Paula A Oliveira; Antonieta Alvarado; Maria J Neuparth; Rita Ferreira; Mário Ginja
Journal:  Clin Exp Med       Date:  2016-04-19       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.